United States · FDA National Drug Code directory

Ixiaro

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62195-051_4465dc2b-20b5-35ba-e063-6394a90a468a
Product NDC: 62195-051
Form: INJECTION, SUSPENSION
Composition / generic term: Japanese Encephalitis Vaccine, Inactivated, Adsorbed
Labeler: Vetter Pharma Fertigung GmbH & Co. KG
Marketing category: BLA
Marketing start / end (source format): 20090330
Source listing expiry: 20261231

Source-listed ingredients

JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED) — 6 ug/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

.5 mL in 1 SYRINGE (62195-051-01) · 62195-051-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →